Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Suzanne Sprague is COO & Global Head of Clearing at CME Group. OQRO lists 9 transactions filed with the SEC under this name, the latest on Sep 17, 2026, each linked to the official Form 4.
COO & Global Head of Clearing
Disclosures on record
9
Companies involved
1
CME GroupCME
9 disclosures · Mar 2025 – Sep 2026 · 1 sold
Sep 15, 20262,864disclosed Sep 17
DetailsOfficial recordSep 15, 2026249disclosed Sep 17
DetailsOfficial recordAs of the latest filing on , Suzanne Sprague reported holding 15,548 shares of CME Group (CME), worth about $4.76M at the last close of $306 (Nov 19, 2026).
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| CME Group CME | 15,548 | 16K direct | $306 | $4.76M | Sep 16, 2026 |
Is this Suzanne Sprague’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
Sep 15, 2026275disclosed Sep 17
DetailsOfficial recordSep 15, 2026320disclosed Sep 17
DetailsOfficial recordSep 16, 2026308disclosed Sep 17
DetailsOfficial recordMar 15, 20265,504disclosed Mar 17
DetailsOfficial recordMar 15, 20262,439disclosed Mar 17
DetailsOfficial recordMar 15, 202676disclosed Mar 17
DetailsOfficial recordMar 3, 2025Sold~$385Kdisclosed Mar 4
DetailsOfficial recordSuzanne Sprague has no open-market purchase on record since 2023. Sales in 2 of the 4 years since 2023.
Suzanne Sprague reported 0 open-market purchases and 2 sales since 2023; no open-market purchase.
| Year | Bought | Sold |
|---|---|---|
| 2025 | — | $385K1×1 trade |
| 2023 | — | $243K1×1 trade |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
On the latest SEC Form 4, dated Sep 16, 2026, Suzanne Sprague reported holding 15,548 shares of CME Group (CME). At the last close of $306 on Nov 19, 2026, that is about $4.76M. This is the stake disclosed in filings, not a net worth.
No public filing gives Suzanne Sprague's net worth. What SEC Form 4 shows is the stock stake: 15,548 shares of CME Group (CME), about $4.76M at the last close. Cash, other investments, property, debts and unexercised options are not in these filings, so the real figure can be much higher or lower.
Suzanne Sprague has no open-market purchase on record since 2023. Sales in 2 of the 4 years since 2023.
In SEC filings since 2023: no open-market purchase is on record; the latest open-market sale is from 2025.
CME Group (CME), from 2023 to 2025: 0 purchases and 2 sales.
Suzanne Sprague reported 0 open-market purchases and 2 sales here, 2023 to 2025.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.